BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12548234)

  • 1. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Rouse DJ; Hirtz DG; Thom E
    Am J Obstet Gynecol; 2003 Jan; 188(1):295. PubMed ID: 12548234
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    McElrath TF
    Am J Obstet Gynecol; 2003 Jan; 188(1):294; author reply 294-5. PubMed ID: 12548232
    [No Abstract]   [Full Text] [Related]  

  • 3. Magnesium sulfate for the prevention of cerebral palsy.
    Mittendorf R; Pryde PG
    N Engl J Med; 2009 Jan; 360(2):189-90; author reply 190. PubMed ID: 19129535
    [No Abstract]   [Full Text] [Related]  

  • 4. Magnesium sulfate and neonatal outcomes of preterm neonates.
    Elimian A; Verma R; Ogburn P; Wiencek V; Spitzer A; Quirk JG
    J Matern Fetal Neonatal Med; 2002 Aug; 12(2):118-22. PubMed ID: 12420842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal risk factors associated with the development of lenticulostriate vasculopathy (LSV) in neonates.
    Mittendorf R; Kuban K; Pryde PG; Gianopoulos JG; Yousefzadeh D
    J Perinatol; 2005 Feb; 25(2):101-7. PubMed ID: 15496867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium sulfate tocolysis: time to quit.
    Grimes DA; Nanda K
    Obstet Gynecol; 2006 Oct; 108(4):986-9. PubMed ID: 17012463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium sulfate: the first-line tocolytic.
    Lewis DF
    Obstet Gynecol Clin North Am; 2005 Sep; 32(3):485-500. PubMed ID: 16125045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast engorgement and galactorrhea during magnesium sulfate treatment of preterm labor.
    Lurie S; Rotmensch S; Feldman N; Glezerman M
    Am J Perinatol; 2002 Jul; 19(5):239-40. PubMed ID: 12152141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor.
    Mittendorf R; Dammann O; Lee KS
    J Perinatol; 2006 Jan; 26(1):57-63. PubMed ID: 16319938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial.
    Lyell DJ; Pullen K; Campbell L; Ching S; Druzin ML; Chitkara U; Burrs D; Caughey AB; El-Sayed YY
    Obstet Gynecol; 2007 Jul; 110(1):61-7. PubMed ID: 17601897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antenatal magnesium sulfate for neuroprotection before preterm birth?
    Stanley FJ; Crowther C
    N Engl J Med; 2008 Aug; 359(9):962-4. PubMed ID: 18753653
    [No Abstract]   [Full Text] [Related]  

  • 12. Marked hypocalcemia after tocolytic magnesium sulphate therapy.
    Nassar AH; Salti I; Makarem NN; Usta IM
    Am J Perinatol; 2007 Sep; 24(8):481-2. PubMed ID: 17853341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Mittendorf R; Dambrosia J; Pryde PG; Lee KS; Gianopoulos JG; Besinger RE; Tomich PG
    Am J Obstet Gynecol; 2002 Jun; 186(6):1111-8. PubMed ID: 12066082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory compromise after MgSO4 therapy for preterm labor in a woman with myotonic dystrophy: a case report.
    Catanzarite V; Gambling D; Bird LM; Honold J; Perkins E
    J Reprod Med; 2008 Mar; 53(3):220-2. PubMed ID: 18441730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of magnesium sulphate in obstetrics.
    Bennett P; Edwards D
    Lancet; 1997 Nov; 350(9090):1491. PubMed ID: 9388392
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Usta IM; Nassar AH
    Am J Obstet Gynecol; 2003 Aug; 189(2):614-5; author reply 615-6. PubMed ID: 14524364
    [No Abstract]   [Full Text] [Related]  

  • 17. Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP).
    Deering SH; Stagg AR; Spong CY; Abubakar K; Pezzullo JC; Ghidini A
    J Matern Fetal Neonatal Med; 2005 Feb; 17(2):151-5. PubMed ID: 16076625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of maternal pharmacological treatment of preterm delivery for neonatal condition].
    Kornacka MK
    Med Wieku Rozwoj; 2003; 7(3 Suppl 1):115-21. PubMed ID: 15537251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Magnesium sulphate in patients at risk for preterm delivery: shall we use it?].
    Deruelle P
    Gynecol Obstet Fertil; 2008 May; 36(5):492-3. PubMed ID: 18467153
    [No Abstract]   [Full Text] [Related]  

  • 20. Magnesium sulfate tocolysis: time to quit.
    Mittendorf R
    Obstet Gynecol; 2007 May; 109(5):1204-5. PubMed ID: 17470609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.